Author:
Pacheco-Rivera R. A.,Hernández-Zamora E.,González-Yebra B.,Beattie K.,Maldonado-Rodríguez R.,Santiago-Hernández J. C.,Medrano-Ortiz de Zárate M. E.,Salcedo M.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference25 articles.
1. Lodish, MB, Stratakis CA (2008) RET oncogene in MEN2, MEN2B, MTC, and other forms of thyroid cancer: molecular genetics and therapeutic advances. Expert Rev Anticancer Ther 8(4): 625–632
2. Eng C, Mulligan LM (1997) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease. Hum Mutat 9(2):97–109
3. Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones 8(1):23–28
4. Mulligan LM, Ponder BA (1995) Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80(7):1989–1995
5. Hidalgo A, Medrano ME, Rodriguez S, Franco C, Martinez I, Benitez L, Salcedo M (1998) Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B. J Exp Clin Cancer Res 17(2):149–152